Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 88-93, September 2010

The Compelling Need for a Cardiology and Oncology Partnership and the Birth of the International CardiOncology Society

  • Daniel J. Lenihan

      Affiliations

    • Division of CV Medicine, Vanderbilt University, Nashville, TN, USA
    • ,
  • Daniela Cardinale

      Affiliations

    • Cardiology Unit, European Institute of Oncology, University of Milan, Milan, Italy
    • ,
  • Carlo M. Cipolla

      Affiliations

    • Cardiology Unit, European Institute of Oncology, University of Milan, Milan, Italy
    • Corresponding Author InformationAddress reprint requests to Carlo M. Cipolla, MD, Cardiology Unit, European Institute of Oncology, Via Ripamonti 435, 20141 Milan, Italy.

Abstract 

Cardiac disease in patients with cancer is common and influences the longevity and quality of life both of patients in active treatment and of survivors of cancer. The disciplines of cardiology and oncology have increasingly recognized the benefits to patients of collaborating in the care of cancer patients with cardiac disease. This increased recognition arises from several factors: the aging population in which both cardiac and cancer diagnoses are common; the cellular and molecular therapeutic targets of newer medical treatments, and, in particular, the specific patient treatment choices and decisions that require careful, effective clinical interactions between these 2 disciplines. Responding to this need for an effective partnership between cardiology and oncology, the International CardiOncology Society was created and has set goals to develop and enhance our understanding and management of these clinical difficulties.

Abbreviations and Acronyms: CV, cardiovascular, ICOS, International CardiOncology Society, VEGF, vascular endothelial growth factor

Keywords: Cardiotoxicity, Chemotherapy, Anti-angiogenesis, Cardiology and oncology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Statement of Conflict of Interest: see page 92.

PII: S0033-0620(10)00107-6

doi:10.1016/j.pcad.2010.06.002

Progress in Cardiovascular Diseases
Volume 53, Issue 2 , Pages 88-93, September 2010

Article Tools